The Safety ,Tolerability and Efficacy Study of HepaCure in Chinese Subjects with Acute-On-Chronic Liver Failure

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Acute on Chronic Hepatic Failure · Liver Failure · Hepatitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing You'an Hospital affiliated to Capital Medical University, Beijing, Beijing Municipality, China
Contact: Study coordinator (YU Chen, MD) · chybeyond@163.com · 8610-83997599

Study leads

YU Chen, MD
Study Chair
Beijing YouAn Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

The Effects of Double Plasma Molecular Adsorption System in Acute on Chronic Liver Failure Patients

Acute-On-Chronic Liver Failure · Acute on Chronic Hepatic Failure

Abroad (travel likely)Recruiting

Bangkok, Thailand

Analysis of Methylomic Features and Prognostic Risk Prediction in Patients With Hepatitis B-related Acute-on-chronic Liver Failure

HBV Related Acute-on-chronic Liver Failure · HBV-related Liver Cirrhosis · HBV (Hepatitis B Virus)

Abroad (travel likely)Recruiting

Jinan, China

Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF

Hepatitis B · Acute-On-Chronic Liver Failure

Abroad (travel likely)Recruiting

Guangzhou, China

Long-term Prognosis of Patients With Hepatitis B Related Acute-on-chronic Liver Failure

Hepatitis B · Acute-On-Chronic Liver Failure

Abroad (travel likely)Recruiting

Guangzhou, China